Nixon Peabody
Bank of America
You are here:  Home  >  Central Coast Health Watch  >  Current Article

Inogen sales, profits soar in third quarter

By   /   Thursday, November 3rd, 2016  /   Comments Off on Inogen sales, profits soar in third quarter

    Print       Email

Inogen revenues, profits and earnings per share were up for the third quarter, the company announced Nov. 3.

Inogen, a Goleta-based manufacturer of direct-to-consumer respiratory products, said revenues increased 33 percent during the quarter from $40.7 million during the same quarter last year to $54.4 million in 2016, which topped analyst revenue estimates of $47.9 million, according to S&P Capital IQ.

Profits increased 28 percent from $2.7 million million in 2015 to $3.5 million in 2016. The company also posted earnings per share of 17 cents, a slight increase over earnings of 14 cents per share in 2015 and four cents higher than analyst estimates of 13 cents per share, according to S&P Capital IQ.

Inogen attributed the earnings growth in part due to an 81 percent increase in units sold. In the past, Inogen relied heavily on rentals of its at-home oxygen concentrators.

The company also increased its revenue guidance for the year to a range of $194 million to $198 million, up from a previous range of $190 million to $194 million.

• Contact Philip Joens at [email protected]

    Print       Email

You might also like...

The Trade Desk beats analyst estimates, shares top $500

Read More →